Skip to main content
INGN
NASDAQ Industrial Applications And Services

Inogen Q2 2026: Revenue Climbs 3%, Adjusted EBITDA Turns Positive, Full-Year Outlook Lifted

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$6.05
Mkt Cap
$163.801M
52W Low
$5.34
52W High
$9.13
52W Position info
13% above low
Off High info
34% below high
Rel. Volume info
1.9× avg
Market data snapshot near publication time

INGN is trading near its 52-week low of $5.34 (13% above the low) on elevated volume (1.9× avg).

Summary

Inogen's Q2 2026 revenue rose 3% to $95.1M, Adjusted EBITDA swung to a positive $2.4M, and full-year guidance was raised. The 10-Q also reveals a separation agreement with a former executive and ongoing share buybacks.


Key Events · Earnings and Guidance · INGN

  • Q2 Revenue and Profitability

    Total revenue reached $95.1M, a 3% year-over-year increase, fueled by a 5.5% rise in sales revenue. The net loss narrowed to $3.85M from $4.15M a year ago. Adjusted EBITDA came in at $2.4M, a dramatic improvement from negative $1.4M in Q1 2026.

  • Full-Year Guidance Raised

    Citing strong international demand and improved gross margins, management raised its full-year 2026 guidance. The positive results were flagged in the August 6 8-K, but the 10-Q provides the detailed financials and confirms the upgraded outlook.

  • Share Repurchase Program

    During the first half of 2026, the company bought back 1.15M shares for $7.5M at an average price of $6.55. With $22.5M remaining under the $30M authorization, the board is signaling confidence in the stock's value.

  • Executive Separation Agreement

    A separation agreement with former executive Michael Bourque, effective July 1, 2026, is included in the 10-Q. The terms provide 12 months of base salary continuation and COBRA reimbursement, replacing prior severance arrangements.


Analysis · INGN · Industrial Applications And Services

A solid second quarter saw Inogen return to revenue growth and positive Adjusted EBITDA, prompting a raise in full-year guidance — a sharp reversal from the prior quarter's negative EBITDA. The filing also details a separation agreement with a former executive and ongoing share repurchases, underscoring management's confidence in the balance sheet. While the recent 8-K previewed the positive momentum, the 10-Q delivers the complete financial picture along with new disclosures on equity grants and insider departures.

How filings like this one have moved

In the 30 days to Sep 18, 2026, 35.4% of the 1168 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.41%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, INGN was trading at $6.05 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $163.8M. The 52-week trading range was $5.34 to $9.13. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

INGN - Latest Insights

INGN
Aug 06, 2026, 4:45 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $6.10
Real-time Price: $5.13 info
Change: -$0.970 (-16%) info
Market Cap: $136.142M info
INGN
Aug 06, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $6.38
Real-time Price: $5.13 info
Change: -$1.25 (-20%) info
Market Cap: $136.142M info
INGN
Jul 01, 2026, 4:09 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $6.70
Real-time Price: $5.13 info
Change: -$1.57 (-23%) info
Market Cap: $136.142M info
INGN
Jun 11, 2026, 4:32 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $6.13
Real-time Price: $5.13 info
Change: -$1.00 (-16%) info
Market Cap: $136.142M info
INGN
May 08, 2026, 4:10 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $7.02
Real-time Price: $5.13 info
Change: -$1.89 (-27%) info
Market Cap: $136.142M info